Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · October 15, 2022

Anakinra Plus Pentoxifylline and Zinc vs Methylprednisolone for Alcohol-Associated Hepatitis

Hepatology (Baltimore, Md.)

 

Additional Info

Hepatology (Baltimore, Md.)
IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis
Hepatology 2022 Oct 01;76(4)1058-1068, G Szabo, M Mitchell, CJ McClain, S Dasarathy, B Barton, AJ McCullough, LE Nagy, A Kroll-Desrosiers, D Tornai, HA Min, S Radaeva, MEB Holbein, L Casey, J Cuthbert

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading